Multidrug-resistant organisms in a community living facility: tracking patient interactions and time spent in common

Mary Elizabeth Bowen1, Jeffrey D Craighead, S Angelina Klanchar

  • 1James A. Haley Veterans Hospital, HSR&D/RR&D Center of Excellence, 8900 Grand Oak Circle, Tampa, FL 33637, USA. mary.bowen3@va.gov

Insights

Contact precautions in community living facilities aim to reduce multidrug-resistant organism (MDRO) spread. This study used real-time surveillance to analyze MDRO-positive patient interactions in shared spaces, informing tailored facility policies.

Area of Science:

  • Infection Control
  • Public Health
  • Healthcare Epidemiology

Background:

  • Contact precautions are standard in community living facilities (CLF) to limit multidrug-resistant organism (MDRO) transmission.
  • Current policies may not fully address environmental and social transmission routes in CLF settings.
  • Shared spaces and devices pose risks for MDRO spread among residents.

Purpose of the Study:

  • To investigate the extent of interactions between multidrug-resistant organism (MDRO)-positive patients and others in communal areas.
  • To identify potential gaps in current contact precaution strategies within community living facilities.
  • To provide data for refining infection control policies in CLF.

Main Methods:

  • Utilized a real-time surveillance system to monitor patient movements and interactions.
  • Focused on community living facility residents identified as positive for multidrug-resistant organisms.
  • Quantified the time spent by MDRO-positive individuals in communal areas with others.

Main Results:

  • MDRO-positive patients engage in significant interactions within communal areas.
  • Real-time data reveals specific high-risk periods and locations for potential MDRO transmission.
  • Current contact precaution measures may be insufficient to prevent transmission in shared environments.

Conclusions:

  • Contact precautions in CLF require enhancement to cover shared spaces and resident interactions.
  • Real-time surveillance offers valuable insights for optimizing infection control strategies.
  • Tailored MDRO policies are essential for improving resident safety in community living facilities.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...